EMORY UNIVERSITY Diversified Active

CIK: 0001377635 · Show all filings

Period: Q1 2015 (← Previous) (Next →)

Filing Date: May 15, 2015

Total Value ($000): $52,879 (100.0% shares, 0.0% debt)

Holdings (10)

VWO VANGUARD INTL EQUITY INDEX F 81.8%

Value ($000) $43,272 Shares 1,058,781 Est. Cost $42.20 Unrealized —

— ANACOR PHARMACEUTICALS INC 2.6%

Value ($000) $1,349 Shares 23,325 Est. Cost $57.83 Unrealized —

BMRN BIOMARIN PHARMACEUTICAL INC 2.3%

Value ($000) $1,211 Shares 9,715 Est. Cost $105.95 Unrealized 0.0%

INCY INCYTE CORP 2.2%

Value ($000) $1,167 Shares 12,729 Est. Cost $82.67 Unrealized 0.0%

— BELLICUM PHARMACEUTICALS INC 2.0%

Value ($000) $1,049 Shares 45,261 Est. Cost $23.18 Unrealized —

— SEATTLE GENETICS INC 2.0%

Value ($000) $1,044 Shares 29,535 Est. Cost $35.35 Unrealized —

— GENOMIC HEALTH INC 1.9%

Value ($000) $983 Shares 32,167 Est. Cost $30.56 Unrealized —

— SYNAGEVA BIOPHARMA CORP 1.8%

Value ($000) $961 Shares 9,854 Est. Cost $97.52 Unrealized —

ACAD ACADIA PHARMACEUTICALS INC 1.8%

Value ($000) $957 Shares 29,356 Est. Cost $34.37 Unrealized 0.0%

BCRX BIOCRYST PHARMACEUTICALS 1.7%

Value ($000) $886 Shares 98,161 Est. Cost $10.35 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
VWO	VANGUARD INTL EQUITY INDEX F	1,058,781	$43,272	81.8%	$42.20	—	FTSE EMR MKT ETF	922042858
—	ANACOR PHARMACEUTICALS INC	23,325	$1,349	2.6%	$57.83	—	COM	032420101
BMRN	BIOMARIN PHARMACEUTICAL INC	9,715	$1,211	2.3%	$105.95	0.0%	COM	09061G101
INCY	INCYTE CORP	12,729	$1,167	2.2%	$82.67	0.0%	COM	45337C102
—	BELLICUM PHARMACEUTICALS INC	45,261	$1,049	2.0%	$23.18	—	COM	079481107
—	SEATTLE GENETICS INC	29,535	$1,044	2.0%	$35.35	—	COM	812578102
—	GENOMIC HEALTH INC	32,167	$983	1.9%	$30.56	—	COM	37244C101
—	SYNAGEVA BIOPHARMA CORP	9,854	$961	1.8%	$97.52	—	COM	87159A103
ACAD	ACADIA PHARMACEUTICALS INC	29,356	$957	1.8%	$34.37	0.0%	COM	004225108
BCRX	BIOCRYST PHARMACEUTICALS	98,161	$886	1.7%	$10.35	0.0%	COM	09058V103